LiverRight, a national virtual liver clinic, and Aegle Medical Solutions, LLC, a provider of advanced liver assessment technology, have announced a strategic partnership aimed at expanding access to non-invasive liver assessment, specialist interpretation, diagnosis, and ongoing care for patients across the United States. The collaboration seeks to address the significant number of adults living with undiagnosed liver disease by creating a more connected and efficient care pathway.
The partnership brings together two complementary organizations. Aegle Medical provides advanced liver assessment technology solutions, including the Mindray Hepatus-Series Transient Elastography Diagnostic Ultrasound Systems, along with implementation, clinical training, and ongoing customer support. LiverRight offers specialist interpretation and access to hepatology clinicians through its national virtual clinic. Together, they aim to help healthcare organizations move patients efficiently from liver disease identification and non-invasive assessment to specialist interpretation, diagnosis, and longitudinal management.
For physicians, health systems, and independent practices, the partnership is designed to make it easier to establish or expand comprehensive liver disease programs without having to build every component internally. Aegle Medical provides a consultative approach to technology evaluation, implementation, training, and ongoing support, while LiverRight can provide same-day interpretation services for liver elastography studies and same-week virtual access to its hepatology clinicians. LiverRight's Liververse™ referral system supports the care pathway by coordinating bloodwork, patient-reported outcomes, available imaging, diagnosis, and longitudinal disease management.
For patients, the combined model is designed to bring advanced liver assessment closer to the communities where they already receive care while improving access to liver specialists. The goal is to create a more efficient pathway from identifying patients who may be at risk to non-invasive assessment, specialist review, diagnosis, and appropriate ongoing care.
"Aegle Medical Solutions is helping hospital systems and independent practices nationwide address the significant number of adults living with undiagnosed liver disease in the United States," said Brandon Tudor, CEO of LiverRight. "By working together, we help practices bring advanced liver assessment into the outpatient setting, provide timely specialist interpretation, and move patients into the appropriate diagnostic and care workflow with greater efficiency."
Michael McTighe, President & CEO of Aegle Medical Solutions, commented, "This strategic partnership with LiverRight represents an important step forward in our shared vision of expanding access to liver disease detection and care within the communities we serve. Aegle Medical has worked to make advanced non-invasive liver assessment technology more accessible to health systems, GI practices, and hepatology programs across the country. By connecting those capabilities with LiverRight's nationwide virtual liver-care network and same-day interpretation services, we can provide our customers with more than technology—we can help them establish a more complete pathway from assessment to diagnosis and ongoing patient management."
McTighe continued, "We believe this model can be particularly valuable for communities where access to hepatology specialists may be limited. Our goal is to help providers identify liver disease earlier, improve access to specialist expertise, and ultimately create a better experience for both patients and clinicians."
The partnership also highlights the Mindray Hepatus platform, which represents a next generation in non-invasive liver assessment. Hepatus introduces Visualized Transient Elastography (ViTE), a breakthrough that integrates real-time B-mode ultrasound visualization directly into the elastography examination. This allows operators to see liver anatomy, identify the optimal measurement location, and visually guide each acquisition while simultaneously obtaining quantitative liver stiffness and attenuation measurements. The Hepatus 6 further expands the platform by combining these capabilities with diagnostic ultrasound imaging, enabling abdominal imaging, Doppler, spleen stiffness assessment, and intestinal ultrasound.
LiverRight has its own hepatologists and hepatology advanced practice providers licensed across all 50 U.S. states, supporting adult patients with liver conditions including MASLD/MASH, alcohol-associated liver disease, hepatitis B and C, primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, and liver cancer diagnosis. The Aegle Medical–LiverRight strategic relationship gives health systems, GI and hepatology practices, and independent providers a scalable approach to expanding liver services under the provider's brand.
